Teladoc Health Inc buy The Goldman Sachs Group, Inc.
Start price
18.02.25
/
50%
€12.54
Target price
18.02.26
€15.31
Performance (%)
-46.70%
Price
04.12.25
€6.69
Summary
This prediction is currently active. Massive losses of -46.70% have been the result for the BUY prediction by The_Goldman_Sachs_Gr. This prediction currently runs until 18.02.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Teladoc Health Inc | 0.451% | 0.451% |
| iShares Core DAX® | 0.142% | -1.511% |
| iShares Nasdaq 100 | 0.833% | -2.600% |
| iShares Nikkei 225® | -0.829% | -7.040% |
| iShares S&P 500 | 0.008% | -1.196% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Teladoc Health Inc diskutieren
Teladoc Health, Inc. (NYSE: TDOC) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $14.00 to $16.00. They now have a "buy" rating on the stock.
Ratings data for TDOC provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Teladoc Health Inc
Teladoc Health Inc
Start price
Target price
Perf. (%)
€9.30
03.03.25
03.03.25
€12.40
03.03.26
03.03.26
-28.10%
04.12.25
04.12.25
Teladoc Health Inc
Start price
Target price
Perf. (%)
€8.99
15.11.24
15.11.24
€13.26
15.11.25
15.11.25
-32.97%
16.11.25
16.11.25

